Ledger.Open graph →
SEC Form D · filed November 15, 2019

Revolution Medicines, Inc

Offering
$100.3M
Sold
$100.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Redwood City, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Dean D. Winick · New York, NYDirectorDavid D. Morse · New York, NYDirectorNeil A. Exter · Redwood City, CADirectorBarbara A. Weber · Redwood City, CADirectorJohn C. Atwater · San Francisco, CADirectorSteve A. Kelsey · Redwood City, CAExecAlexis A. Borisy · Redwood City, CADirectorDale Jones · Argyle, TXExec · DirectorTodd Owens · Seattle, WADirectorBrien P. Smith · Dallas, TXDirectorNeil A. Exter · Redwood City, CADirectorSteven A. Gerstung · San Francisco, CADirectorDaniel H. James · San Francisco, CADirectorJen Thomson · Grand Cayman, Cayman IslandsExecJon W. Brayshaw · San Francisco, CADirectorDavid D. Morse · New York, NYExec · DirectorJames B. Saad · Loxley, ALExecElizabeth A. Anderson · Redwood City, CADirectorMatthew N. Bird · New York, NYDirectorGreg Gottesman · Seattle, WAExecThilo A. Schroeder · Redwood City, CADirectorScott G. Douglass · San Francisco, CADirectorVincent A. Miller · Redwood City, CADirectorHenry Ellenbogen · Chevy Chase, MDDirectorLaurence A. Lasky · Redwood City, CADirectorMark A. Goldsmith · Redwood City, CAExec · DirectorMargaret A. Horn · Redwood City, CAExecAnne-Sophie Davreux · Senningerberg, LuxembourgDirectorJaret Walker · Denton, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗